Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
147
datasets available to search
ShareScore release 0.9.0
Dataset results
147 results for “vildagliptin”
A Sub-study to LMF237A2302 to Assess the Effect of 24 Weeks Treatment With Initial Combination of Vildagliptin Plus Metformin
ClinicalTrials.gov study NCT00468039. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Vildagliptin in New Onset Diabetes After Transplantation
ClinicalTrials.gov study NCT00980356. IPD Sharing: Not stated. Countries: 1. Publications: 3.
A 56-Week Extension to a Clinical Study to Assess the Efficacy and Safety of Vildagliptin Compared to Placebo in Drug Naive Patients With Type 2 Diabetes and Mild Hyperglycemia
ClinicalTrials.gov study NCT00300287. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Vildagliptin and Endothelium-dependent Vasodilatation
ClinicalTrials.gov study NCT01000688. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Vildagliptin add-on to Glimepiride Versus Placebo Added to Glimepiride in Type 2 Diabetes
ClinicalTrials.gov study NCT01357252. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Vildagliptin Versus Liraglutide - Patient Preference After Receiving Both Medications
ClinicalTrials.gov study NCT01518101. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Extension to a Study on the Efficacy and Safety of Vildagliptin in Combination With Insulin in Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT00138606. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Bioequivalence Study of Vildagliptin From Gliptus 50 mg Tablet (EVA Pharma, Egypt) and Galvus 50 mg Tablet (NOVARTIS PHARMA, GERMANY)
ClinicalTrials.gov study NCT02816970. IPD Sharing: UNDECIDED. Countries: 1. Publications: 3.
Effect of Vildagliptin on Left Ventricular Function in Patients With Type 2 Diabetes and Congestive Heart Failure
ClinicalTrials.gov study NCT00894868. IPD Sharing: Not stated. Countries: 15. Publications: 1.
Efficacy and Safety of Vildagliptin Compared to Rosiglitazone in Drug Naive Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT00099918. IPD Sharing: Not stated. Countries: 2. Publications: 3.
Extension to a Study on the Efficacy and Safety of Vildagliptin in Combination With Pioglitazone in Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT00138554. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Prevention of Diabetes After Transplantation by Vildagliptin in the Early Post-transplant Period
ClinicalTrials.gov study NCT02849899. IPD Sharing: NO. Countries: 1. Publications: 1.
To Assess the Efficacy and Safety of Vildagliptin as Add-on Therapy to Sulfonylurea in Patients With Type 2 Diabetes Inadequately Controlled With Sulfonylurea Monotherapy
ClinicalTrials.gov study NCT00325117. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Clinical Trial to Study the Effects of Two Drugs, Vildagliptin and Metformin in Patients With Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT02853630. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Efficacy of Vildagliptin 100 MG as Compared to Placebo as Add-on to Metformin in Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT00351884. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Extension to a Study on the Efficacy and Safety of Vildagliptin Compared to Rosiglitazone in Drug Naive Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT00138619. IPD Sharing: Not stated. Countries: 2. Publications: 1.
The Effect of Vildagliptin Based Treatment Versus Sulfonylurea on Glycemic Variability, Oxidative Stress, GLP-1, and Endothelial Function in Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT01404676. IPD Sharing: NO. Countries: 1. Publications: 1.
Effect of Acarbose and Vildagliptin on Visceral Fat Distribution in Newly Diagnosed Type 2 Diabetes Patients
ClinicalTrials.gov study NCT02999841. IPD Sharing: NO. Countries: 1. Publications: 6.
Efficacy of add-on Therapy With Vildagliptin in Chinese Patients With Type 2 Diabetes Inadequately Controlled With Prior Metformin Monotherapy
ClinicalTrials.gov study NCT00822211. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Clinical Study to Assess the Efficacy and Safety of Three Doses of Vildagliptin in Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT00099905. IPD Sharing: Not stated. Countries: 1. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.